|
|
1/17/2023
|
|
When:
|
Tuesday, January 17, 2023 12:00pm ET
|
|
Where:
|
https://us06web.zoom.us/webinar/register/WN_v9TVPevPSRqAZfRvA6dMzQ
|
|
Contact:
|
Kayti Mangels
kmangels@oup.vc
|
|
|
« Go to Upcoming Event List
|
|
|
Please join us for the first part of the patient data licensing series which focuses on the policies and procedures of data management, including what can be licensed. Our panelists, Nick Gruszauskas of the University of Chicago and David Peloquin of Ropes & Gray, will review: • The types of data and data definitions • Key statutes associated with patient data • Policies and processes on data, including: - Identifiable vs. de-identified - The consent process and types of consents - The role of IRB and other stakeholders (oversight committees, ethics, committees, sponsored programs, tech transfer, general counsel, etc.) • Ownership and use
The webinar will be held on January 17, 2023 at noon-1pm ET/11-noon CT/10am-11am MT/9-10am PT.
Please contact kleute@oup.vc with any questions you’d like us to pose to the panelists or submit your questions below.
The other two session for the series are as follows and registration for these will be open at future dates.
2. What can we do with the data? (March 21, 2023) The panelists, John Plummer of the Vanderbilt Medical Center and Gavin Foltz of Duke University, will review the transfer and protection of patient data via: • Clinical trial agreements • Non-clinical industry-nonprofit agreements (sponsored research agreements) • DUAs and use rights • BAAs • Licensing agreements
3. How are academic institutions licensing patient data? (May 16, 2023) This is the nitty-gritty on the licensing considerations for patient data during which your panelists Stephen Gardner of Quarles & Brady and Angela Kujak of The Broad Institute which will cover: • License structure types • Valuation - Use vs incorporation vs productization • Sublicensing rights • Reproduction/modification/combination - PHI considerations/clauses - Institutional approvals - Combination products (Data + devices/diagnostics) - Security measures - Auditing and liabilities • Inventorship and revenue distribution
We look forward to having you join us!
|
|
|